Inhibrx Biosciences Statistics
Total Valuation
INBX has a market cap or net worth of $1.12 billion. The enterprise value is $1.04 billion.
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INBX has 14.49 million shares outstanding. The number of shares has increased by 13.93% in one year.
| Current Share Class | 14.49M |
| Shares Outstanding | 14.49M |
| Shares Change (YoY) | +13.93% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.01% |
| Owned by Institutions (%) | 44.90% |
| Float | 8.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 797.22 |
| Forward PS | n/a |
| PB Ratio | 16.27 |
| P/TBV Ratio | 16.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 740.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.98, with a Debt / Equity ratio of 1.56.
| Current Ratio | 4.98 |
| Quick Ratio | 4.82 |
| Debt / Equity | 1.56 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.97 |
Financial Efficiency
Return on equity (ROE) is -113.71% and return on invested capital (ROIC) is -31.17%.
| Return on Equity (ROE) | -113.71% |
| Return on Assets (ROA) | -26.29% |
| Return on Invested Capital (ROIC) | -31.17% |
| Return on Capital Employed (ROCE) | -57.14% |
| Revenue Per Employee | $8,696 |
| Profits Per Employee | -$1.02M |
| Employee Count | 161 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 46.73 |
Taxes
In the past 12 months, INBX has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +381.56% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +381.56% |
| 50-Day Moving Average | 33.26 |
| 200-Day Moving Average | 19.68 |
| Relative Strength Index (RSI) | 83.91 |
| Average Volume (20 Days) | 636,932 |
Short Selling Information
The latest short interest is 532,661, so 3.68% of the outstanding shares have been sold short.
| Short Interest | 532,661 |
| Short Previous Month | 524,531 |
| Short % of Shares Out | 3.68% |
| Short % of Float | 6.53% |
| Short Ratio (days to cover) | 6.46 |
Income Statement
In the last 12 months, INBX had revenue of $1.40 million and -$163.69 million in losses. Loss per share was -$10.58.
| Revenue | 1.40M |
| Gross Profit | -171.77M |
| Operating Income | -98.95M |
| Pretax Income | -163.69M |
| Net Income | -163.69M |
| EBITDA | -96.17M |
| EBIT | -98.95M |
| Loss Per Share | -$10.58 |
Full Income Statement Balance Sheet
The company has $186.57 million in cash and $106.79 million in debt, giving a net cash position of $79.78 million or $5.51 per share.
| Cash & Cash Equivalents | 186.57M |
| Total Debt | 106.79M |
| Net Cash | 79.78M |
| Net Cash Per Share | $5.51 |
| Equity (Book Value) | 68.56M |
| Book Value Per Share | 4.74 |
| Working Capital | 155.03M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$139.85 million and capital expenditures -$284,000, giving a free cash flow of -$140.13 million.
| Operating Cash Flow | -139.85M |
| Capital Expenditures | -284,000 |
| Free Cash Flow | -140.13M |
| FCF Per Share | -$9.67 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | -7,068.14% |
| Pretax Margin | -11,692.29% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INBX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.93% |
| Shareholder Yield | -13.93% |
| Earnings Yield | -14.67% |
| FCF Yield | -12.56% |
Dividend Details Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
INBX has an Altman Z-Score of -0.99 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.99 |
| Piotroski F-Score | 1 |